Wednesday, April 5, 2017
NeoThetics (NEOT) announces the USPTO issuance of a patent
NeoThetics announces the USPTO issuance of a patent directed to specific methods of using LIPO-202 and other agents for the reduction of fat accumulation (NEOT) : The '531 patent is expected to expire no earlier than the fourth quarter of 2031, extending the coverage time of the company's intellectual property portfolio.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment